The growing demand for controlled immunological study and therapeutic development has spurred significant improvements in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently manufactured using various expression systems, including prokaryotic hosts, higher cell lines, and vira